22 August 2019

Hans van Bokhoven, theme Neurodevelopmental disorders, is elected as a new member of the Academia Europaea.

Hans van Bokhoven’s research is aimed at unravelling the genetic causes of congenital brain disorders, such as intellectual disabilities, autism, epilepsy and neuromuscular diseases. He applies knowledge of genetic variants that are responsible for these disorders to obtain further insight into the exact molecular and cellular processes that are disrupted by these. His research uses model organisms (fruit flies) to study specific genetic disorders, for example Kleefstra syndrome. Increasing use is also made of patients’ stem cells from which cell types (neurons) are grown that are physiologically relevant for the disorders in question. The aim of his research is to provide new insight into the mechanism of disease and to develop new strategies for therapy.

The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members. Membership is only by invitation after peer group nomination, scrutiny and confirmation as to the scholarship and eminence of the individual in their chosen field. Election is confirmed by the Council of the Academia. Members are drawn from across the whole European continent, not only Western Europe. Members also include European scholars who are resident in other regions of the world. Current membership stands at around 4000. Amongst them are seventy-two Nobel Laureates, several of whom were elected to the Academia before they received the prize.

In addition to Hans van Bokhoven, Nicoline Hoogerbrugge, Michiel Vermeulen, Bart Jan Kullberg, Bas Bloem, Joost Hoenderop, Bart Kiemeney, Barbara Franke, Guillen Fernandez, Mihai Netea, John Jansen, Jan Smeitink, Carl Figdor, Jos van der Meer, Han Brunner, René Bindels, Han van Krieken, Maroeska Rovers, Nico Verdonschot and Joost Drenth are also members of the Academia Europaea.

Related news items


Online intervention for women exposed to intimate partner violence

21 November 2019

Within the SAFE project from the department of Primary and Community Care an eHealth intervention has been developed for women exposed to intimate partner violence (IPV).

read more

Technology for Oncology II grant application funded

21 November 2019

The grant application called "aiREAD – Accurate and Intelligent Reading for EArlier breast cancer Detection” by project leader Ioannis Sechopoulos, has been selected for funding under the NWO TTW – KWF Kankerbestrijding – Top Sector LSH Partnership “Technology for Oncology II”.

read more

KNCV Golden Master Award call for nominations

20 November 2019

The Royal Netherlands Chemistry Society awards this prize each year to the best Master’s research project. The Master’s thesis must relate to research in the field of chemistry, life sciences, process technology or (bio-)molecular sciences. Deadline: 31-12-2019.

read more

Podosome nanoscale architecture redefined

20 November 2019

Koen van den Dries and Alessandra Cambi, theme Nanomedicine, revealed how the nanoscale architecture of podosomes enables dendritic cells to protrude and sense their extracellular environment. They have published their results in Nature Communications.

read more

270 times Homo Universalis in Nijmegen

20 November 2019

What does a scientist of the future look like? International young scientists addressed this important topic during the ENABLE conference, organized by young researchers for young researchers. They showed how the new generation of researchers wants to open up science to the public.

read more

More expertise needed for patients with prolonged Disorder of Consciousness

14 November 2019

Willemijn van Erp published in the Annals of Neurology that nearly 80% of people with Unresponsive Wakefulness Syndrome, formerly referred to as ‘vegetative state’, are not given a correct description of the diagnosis when they are discharged from the hospital.

read more